Applying FDA Marketing Regulations to Internet Promotions List of most commonly cited violations
At the recent CBI eMarketing for the Pharmaceutical Industry conference held in Philadelphia, PA, Preeti Pinto, M.S., Senior Director Promotional Regulatory Affairs, AstraZeneca, gave the attendees some insight on the regulatory actions taken by the FDA with respect to online DTC marketing by pharmaceutical companies. She summarized the most commonly cited violations found on pharmaceutical company web pages.
Topics covered include:
- List of most commonly cited violations
- Be Careful With Web Site Names
- Online Clinical Trial Registries
- Table: Pharmaceutical Website Marketing Violations
Read this article now. It’s FREE…
PMN43-05
Issue: Vol. 4, No. 3: March 2005
Word Count: 664
Find other articles in related Topic Areas:
